simulect
novartis indonesia - indonesia - basiliximab - serbuk injeksi - 20 mg
avaxim 80 u pediatric
aventis pharma - indonesia - hepatitis a immunoglobulin human - cairan injeksi - 80 unit/0,5 ml
granocyte 34 serbuk injeksi 263 mcg/vial
aventis pharma - indonesia - lenograstim - serbuk injeksi - 263 mcg/vial
vivaxim
aventis pharma - indonesia - hepatitis a immunoglobulin human; salmonella typhi-immunogen - cairan injeksi
hexaxim cairan injeksi
aventis pharma - indonesia - diphteria toxoid protein; fha; filamentous hemagglutinin; haemophilus influenzae b; hepatitis b surface antigen (hbs ag); inactivated polio virus type 1; inactivated polio virus type 2; inactivated polio virus type 3; pertussistoxoid med aluminiumhydroxid; tetanus toxoid - cairan injeksi
vivaxim
aventis pharma - indonesia - typhoid vi polysaccharide, inactivated hepatitis a virus - suspensi injeksi - 25 mcg /160 iu
simulect
novartis indonesia - indonesia - basiliximab - serbuk injeksi - 20 mg
avaxim 80 u pediatric
aventis pharma - indonesia - inactivated hepatitis a virus - injeksi - 80 elisa unit
granocyte 34
aventis pharma - indonesia - lenograstim - serbuk injeksi - 33.6 miu
tetraxim
aventis pharma - indonesia - tetanus toxoid, diphteria toxoid, pertussis toxoid, filamentous haemagglutinin, inactivated poliomyelitis virus type 1 (mahoney strain), inactivated poliomyelitis virus type 2 (mef strain), inactivated poliomyelitis virus type 3 (saukett strain) - suspensi injeksi - nlt 40 iu /nlt 30 iu /25 mcg /25 mcg /40 du /8 du /32 du